Drug Profile
Diphtheria tetanus pertusis-hepatitis B vaccine - Bharat Biotech
Alternative Names: Comvac4; ComVac4-Hb; Diphtheria, tetanus, pertussis whole cell and recombinant hepatitis B vaccine - Bharat Biotech; DTwPHib - Bharat BiotechLatest Information Update: 23 Jan 2018
Price :
$50
*
At a glance
- Originator Bharat Biotech
- Class Bacterial vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 08 Jan 2018 Bharat Biotech completes a phase III trial in infant volunteers in India (IM) (CTRI2017-01-007706)
- 19 Feb 2016 Launched for Diphtheria in India (IM) before February 2016 (Bharat Biotech pipeline; February 2016)
- 19 Feb 2016 Launched for Hepatitis B in India (IM) (Bharat Biotech pipeline; February 2016)